Holdings
Sarissa Capital Management LP
As of Jun 30, 2026, Sarissa Capital Management LP reported 9 positions worth US$151M. Largest: Innoviva, Inc., Ironwood Pharmaceuticals, Inc. and Neurocrine Biosciences, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Innoviva, Inc. | 1.89M | US$42.9M | −240K | Jun 30, 2026 |
| Ironwood Pharmaceuticals, Inc. | 9.19M | US$38.7M | no change | Jun 30, 2026 |
| Neurocrine Biosciences, Inc. | 117K | US$19.6M | no change | Jun 30, 2026 |
| Cytokinetics, Incorporated | 229K | US$19.5M | no change | Jun 30, 2026 |
| Lantheus Holdings, Inc. | 167K | US$18.5M | no change | Jun 30, 2026 |
| Biohaven Ltd. | 582K | US$8.66M | +19,128 | Jun 30, 2026 |
| Regeneron Pharmaceuticals, Inc. | 4,190 | US$2.61M | no change | Jun 30, 2026 |
| Vor Biopharma Inc. | 25,399 | US$468K | no change | Jun 30, 2026 |
| Biogen Inc. | 950 | US$205K | new | Jun 30, 2026 |